Brief: GSK Receives First Global Approval For Hibsago In Japan
24/08/2026 07:22
BRIEF-GSK Receives First Global Approval For Hibsago In Japan Aug 24 (Reuters) - GSK plc GSK.L:
GSK PLC - FIRST GLOBAL APPROVAL FOR HIBSAGO IN JAPAN
GSK PLC - FIRST GLOBAL APPROVAL FOR HIBSAGO IN JAPAN
GSK - JAPAN APPROVES HIBSAGO (BEPIROVIRSEN) AS FUNCTIONAL CURE FOR CHRONIC HEPATITIS B
Source text: ID:nRSX8441Ra
Further company coverage: GSK.L
((Reuters.Briefs@thomsonreuters.com;;))